173 related articles for article (PubMed ID: 12562253)
1. Hereditary nonpolyposis colorectal cancer syndrome in a patient with urothelial carcinoma of the upper urothelial tract.
Hartmann A; Cheville JC; Dietmaier W; Hofstädter F; Burgart LJ; Blaszyk H
Arch Pathol Lab Med; 2003 Feb; 127(2):E60-3. PubMed ID: 12562253
[TBL] [Abstract][Full Text] [Related]
2. Upper tract urothelial carcinoma: a clinicopathologic study including microsatellite instability analysis.
Blaszyk H; Wang L; Dietmaier W; Hofstädter F; Burgart LJ; Cheville JC; Hartmann A
Mod Pathol; 2002 Aug; 15(8):790-7. PubMed ID: 12181263
[TBL] [Abstract][Full Text] [Related]
3. Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum.
Rouprêt M; Yates DR; Comperat E; Cussenot O
Eur Urol; 2008 Dec; 54(6):1226-36. PubMed ID: 18715695
[TBL] [Abstract][Full Text] [Related]
4. Universal Point of Care Testing for Lynch Syndrome in Patients with Upper Tract Urothelial Carcinoma.
Metcalfe MJ; Petros FG; Rao P; Mork ME; Xiao L; Broaddus RR; Matin SF
J Urol; 2018 Jan; 199(1):60-65. PubMed ID: 28797715
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Lynch syndrome among patients with upper urinary tract carcinoma in a Japanese hospital-based population.
Ito T; Kono K; Eguchi H; Okazaki Y; Yamamoto G; Tachikawa T; Akagi K; Okada Y; Kawakami S; Morozumi M; Tamaru JI; Ishida H
Jpn J Clin Oncol; 2020 Jan; 50(1):80-88. PubMed ID: 31665498
[TBL] [Abstract][Full Text] [Related]
6. Lynch Syndrome: A Primer for Urologists and Panel Recommendations.
Mork M; Hubosky SG; Rouprêt M; Margulis V; Raman J; Lotan Y; O'Brien T; You N; Shariat SF; Matin SF
J Urol; 2015 Jul; 194(1):21-9. PubMed ID: 25711197
[TBL] [Abstract][Full Text] [Related]
7. A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi-institutional database analysis: proposal of patient-specific risk identification tool.
Audenet F; Colin P; Yates DR; Ouzzane A; Pignot G; Long JA; Soulie M; Phé V; Bensadoun H; Guy L; Ruffion A; Valeri A; Cormier L; Droupy S; de La Taille A; Saint F; Faïs PO; Houlgatte A; Cussenot O; Rouprêt M;
BJU Int; 2012 Dec; 110(11 Pt B):E583-9. PubMed ID: 22703159
[TBL] [Abstract][Full Text] [Related]
8. Molecular subtype classification of urothelial carcinoma in Lynch syndrome.
Therkildsen C; Eriksson P; Höglund M; Jönsson M; Sjödahl G; Nilbert M; Liedberg F
Mol Oncol; 2018 Aug; 12(8):1286-1295. PubMed ID: 29791078
[TBL] [Abstract][Full Text] [Related]
9. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
[TBL] [Abstract][Full Text] [Related]
10. Urinary Tract Cancer in Lynch Syndrome; Increased Risk in Carriers of MSH2 Mutations.
Joost P; Therkildsen C; Dominguez-Valentin M; Jönsson M; Nilbert M
Urology; 2015 Dec; 86(6):1212-7. PubMed ID: 26385421
[TBL] [Abstract][Full Text] [Related]
11. [Hereditary nonpolyposis colorectal carcinoma (HNPCC): surgical aspects].
Möslein G
Praxis (Bern 1994); 2001 Mar; 90(12):483-9. PubMed ID: 11324307
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis colorectal cancer.
Ramsey SD; Clarke L; Etzioni R; Higashi M; Berry K; Urban N
Ann Intern Med; 2001 Oct; 135(8 Pt 1):577-88. PubMed ID: 11601929
[TBL] [Abstract][Full Text] [Related]
13. Hereditary nonpolyposis colorectal cancer (Lynch syndrome): criteria for identification and management.
Kouraklis G; Misiakos EP
Dig Dis Sci; 2005 Feb; 50(2):336-44. PubMed ID: 15745097
[TBL] [Abstract][Full Text] [Related]
14. [Hereditary nonpolyposis colorectal carcinoma (HNPCC). Current review of etiology, clinical aspects, diagnosis and therapy].
al-Taie O; Mörk H; Seufert J; Treis H; Jakob F; Scheurlen M
Med Klin (Munich); 2001 Sep; 96(9):529-38. PubMed ID: 11603116
[TBL] [Abstract][Full Text] [Related]
15. [Metachronous urothelial cancer in bilateral upper urinary tracts and bladder associated with hereditary nonpolyposis colorectal cancer].
Yamada Y; Ueda Y; Higuchi Y; Suzuki T; Maruyama T; Kondoh Y; Nojima M; Noda M; Tomita N; Zozumi M; Hirota S; Yamamoto S
Hinyokika Kiyo; 2011 Oct; 57(10):559-63. PubMed ID: 22089154
[TBL] [Abstract][Full Text] [Related]
16. Hereditary nonpolyposis colorectal cancer: preventive management.
Annie Yu HJ; Lin KM; Ota DM; Lynch HT
Cancer Treat Rev; 2003 Dec; 29(6):461-70. PubMed ID: 14585257
[TBL] [Abstract][Full Text] [Related]
17. Urothelial carcinoma of the upper urinary tract: inverted growth pattern is predictive of microsatellite instability.
Hartmann A; Dietmaier W; Hofstädter F; Burgart LJ; Cheville JC; Blaszyk H
Hum Pathol; 2003 Mar; 34(3):222-7. PubMed ID: 12673555
[TBL] [Abstract][Full Text] [Related]
18. Urinary tract cancer and hereditary nonpolyposis colorectal cancer: risks and screening options.
Sijmons RH; Kiemeney LA; Witjes JA; Vasen HF
J Urol; 1998 Aug; 160(2):466-70. PubMed ID: 9679899
[TBL] [Abstract][Full Text] [Related]
19. [Two cases of bladder cancer with hereditary nonpolyposis colorectal cancer].
Kawaoka T; Miyagawa Y; Tsujihata M; Kamoto A; Nonomura N; Okuyama A
Hinyokika Kiyo; 2011 Jun; 57(6):319-21. PubMed ID: 21795835
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological characteristics of patients with upper urinary tract urothelial cancer with loss of immunohistochemical expression of the DNA mismatch repair proteins in universal screening.
Urakami S; Inoshita N; Oka S; Miyama Y; Nomura S; Arai M; Sakaguchi K; Kurosawa K; Okaneya T
Int J Urol; 2018 Feb; 25(2):151-156. PubMed ID: 29164703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
